Last updated on December 2018

An Investigational Immuno-therapy Trial of Nivolumab or Nivolumab Plus Ipilimumab or Nivolumab Plus Platinum-doublet Chemotherapy Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)


Brief description of study

The purpose of this study is to show that Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus Platinum-Doublet Chemotherapy improves progression free survival and/or overall survival compared with chemotherapy in patients with advanced lung cancer.

Clinical Study Identifier: NCT02477826

Find a site near you

Start Over

Local Institution

La Jolla, CA United States
  Connect »

California Pacific Medical Center

San Francisco, CA United States
  Connect »

Yale University

New Haven, CT United States
  Connect »

Baptist Health Lexington

Lexington, KY United States
  Connect »

Local Institution

Boston, MA United States
  Connect »

Local Institution

Southfield, MI United States
  Connect »

Local Institution

Rochester, MN United States
  Connect »

Lehigh Valley Health Network

Allentown, PA United States
  Connect »

St. Mary Medical Center

Langhorne, PA United States
  Connect »

Thomas Jefferson University

Philadelphia, PA United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

Greenville Health System

Greenville, SC United States
  Connect »

Coiba

Berazategui, Argentina
  Connect »

Instituto Alexander Fleming

Capital Federal, Argentina
  Connect »

Hospital Italiano De Buenos Aires

Ciudad Autonoma De Buenos Aire, Argentina
  Connect »

Fundacion Investigar

Ciudad de Buenos Aires, Argentina
  Connect »

Centro Medico San Roque

San Miguel de Tucuman, Argentina
  Connect »

Local Institution

Elizabeth Vale, Australia
  Connect »

Akh Wien

Vienna, Austria
  Connect »

Local Institution

Sint Niklaas, Belgium
  Connect »

Local Institution

Porto Alegre, Brazil
  Connect »

Local Institution

Rio De Janeiro, Brazil
  Connect »

Plicni Klinika

Hradec Kralove, Czechia
  Connect »

Local Institution

ANGERS Cedex 2, France
  Connect »

Local Institution

Limoges Cedex, France
  Connect »

Local Institution

Marseille Cedex 20, France
  Connect »

Local Institution

Rennes Cedex 9, France
  Connect »

Local Institution

Saint Herblain, France
  Connect »

Local Institution

Saint Priest En Jarez, France
  Connect »

Local Institution

Thessaloniki, Greece
  Connect »

Local Institution

Petach Tikva, Israel
  Connect »

Local Institution

Tel-hashomer, Israel
  Connect »

Local Institution

S.Andrea Fratte PG, Italy
  Connect »

Local Institution

Matsuyama-shi, Japan
  Connect »

Local Institution

Hiroshima-shi, Japan
  Connect »

Local Institution

Kanazawa-shi, Japan
  Connect »

Local Institution

Yokohama-Shi, Japan
  Connect »

Local Institution

Yokohama-shi, Japan
  Connect »

Local Institution

Kurashiki-shi, Japan
  Connect »

Local Institution

Hirakata-shi, Japan
  Connect »

Local Institution

Osakasayama-shi, Japan
  Connect »

Local Institution

Takatsuki-shi, Japan
  Connect »

Local Institution

Kitaadachi-gun, Japan
  Connect »

Local Institution

Wakayama-shi, Japan
  Connect »

Local Institution

Cheongju-si, Korea, Republic of
  Connect »

Local Institution

Seongnam-si, Korea, Republic of
  Connect »

Local Institution

Seoul, Korea, Republic of
  Connect »

Local Institution

San Luis Potosi, Mexico
  Connect »

Local Institution

Amsterdam, Netherlands
  Connect »

Local Institution

Rotterdam, Netherlands
  Connect »

Local Institution

Veldhoven, Netherlands
  Connect »

Local Institution

Chelyabinsk, Russian Federation
  Connect »

Local Institution

Kazan, Russian Federation
  Connect »

Local Institution

Moscow, Russian Federation
  Connect »

Local Institution

Saint-Petersburg, Russian Federation
  Connect »

Local Institution

St. Petersburg, Russian Federation
  Connect »

Local Institution

Ufa, Russian Federation
  Connect »

Local Institution

Riyadh 11426, Saudi Arabia
  Connect »

Local Institution

Riyadh-11211, Saudi Arabia
  Connect »

Local Institution

Johannesburg, South Africa
  Connect »

Local Institution

Pretoria, South Africa
  Connect »

Local Institution

Saxonwold, Johannesburg, South Africa
  Connect »

Local Institution

Vereeniging, South Africa
  Connect »

Local Institution

Badalona (Barcelona), Spain
  Connect »

Local Institution

Winterthur, Switzerland
  Connect »

Local Institution

Tao-yuan County, Taiwan
  Connect »

Local Institution

Al Ain, United Arab Emirates
  Connect »

Local Institution

Middlesborough, United Kingdom
  Connect »

Local Institution

London, United Kingdom
  Connect »

Local Institution

Southampton, United Kingdom
  Connect »

Local Institution

Leicester, United Kingdom
  Connect »

Local Institution

Edinburgh, United Kingdom
  Connect »

Local Institution

Birmingham, United Kingdom
  Connect »

Local Institution

Cambridgeshire, United Kingdom
  Connect »

Local Institution

Surrey, United Kingdom
  Connect »

Emory University Hospital

Atlanta, GA United States
  Connect »

University Hospitals

Cleveland, OH United States
  Connect »

The Ohio State University

Columbus, OH United States
  Connect »

Hollings Cancer Center

Charleston, SC United States
  Connect »

St Francis Hospital

Greenville, SC United States
  Connect »

The University Of Texas

Dallas, TX United States
  Connect »

COIBA

Berazategui, Argentina
  Connect »

Blacktown Hospital

Blacktown, Australia
  Connect »

Tamworth Hospital

Tamworth, Australia
  Connect »

Plicni klinika

Hradec Kralove, Czechia
  Connect »

Local Institution

Limoges cedex, France
  Connect »

Local Institution

Tao-Yuan County, Taiwan
  Connect »

Local Institution

Besançon Cedex, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.